Bullous conge~itai ichthyosiform erythroderma is a human hereditary skin disorder in which suprabasal keratinocytes rupture. Recent reports have implicated keratins K1 and K10 in this disease. Here we describe four diverse keratin mutations t hat are all significantly associated with this disease. Two of these are in the helix 1A subdomain of the type II keratin 1, giving a serin e-to-proline substitution in codon 185 and an asparagine-to-serine substitution in codon 187. In the analogous region of type I keratin 10, an arginine-to-pro-K eratins are the major intermediate filament proteins found in the cytoskeleton of epithelial cells. These proteins assemble as coiled-coil heterodimers consisting o~ a specific type I (acidic) and type II (basic) kera tin [1] [2] [3] .. Dimers undergo further polymerisation t. o form keratin intermediate fil ame nts by an assembly process that has yet to be fully defined. Keratins are expressed as pairs in a tissue-specific manner. In the basal cells of epidermis in the skin, synthesis of keratins K5 (type II) and K14 (type I) predominate, w hereas in the outer suprabasallayers of the epidermis, keratins K1 (type II) and K10 (type I) constitute the majority of the cellular protein.
Bullous conge~itai ichthyosiform erythroderma is a human hereditary skin disorder in which suprabasal keratinocytes rupture. Recent reports have implicated keratins K1 and K10 in this disease. Here we describe four diverse keratin mutations t hat are all significantly associated with this disease. Two of these are in the helix 1A subdomain of the type II keratin 1, giving a serin e-to-proline substitution in codon 185 and an asparagine-to-serine substitution in codon 187. In the analogous region of type I keratin 10, an arginine-to-pro-K eratins are the major intermediate filament proteins found in the cytoskeleton of epithelial cells. These proteins assemble as coiled-coil heterodimers consisting o~ a specific type I (acidic) and type II (basic) kera tin [1] [2] [3] .. Dimers undergo further polymerisation t. o form keratin intermediate fil ame nts by an assembly process that has yet to be fully defined. Keratins are expressed as pairs in a tissue-specific manner. In the basal cells of epidermis in the skin, synthesis of keratins K5 (type II) and K14 (type I) predominate, w hereas in the outer suprabasallayers of the epidermis, keratins K1 (type II) and K10 (type I) constitute the majority of the cellular protein.
A direct role for keratins in maintaining the structural integrity of skin has recently been demonstrated by findings that certain point mutations in either of the K5 and K14 keratin ge nes are strongly associated with the autosomal dominan t blistering disorder epidermolysis bullosa simpl ex (EBS) , where blistering occurs through lysis of epidermal keratinocytes in the basal cell layer [4] [5] [6] . Similarly, suprabasal splitting by cytolysis has been found to occur in BCIE [7, 8] , a dominant disorder characterised by pronounced hyManuscript received September l , 1993; accepted for publication O ctober 19,1993. Presented in part at th e 54th Annual Meetin g of the Society for Investigative Dermatology, Washington D.C., April 1993. line and an arginine-to-serine transition in codon 156 have been identified. All four mutations create restriction fragment length polymorphisms that were used exclude the mutations from 120 normal chromosomes. Insertional polymorphism (in the V2 subdomains of the non-helical tails of K1 and K10) was excluded as the cause of the phenotypic heterogeneity observed within one family.
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Dermatol102: 24 -30, 1994 perkeratosis, ichthyosis, and erythroderma [9, 10] . This condition is also referred to as epidermol ytic hyperkeratosis (EH, EHK). Recently, mutations associated with this disease have been reported in keratins 1 and 10 [11] [12] [13] . It has been shown by in vitro experiments that artificial mutations in these regions of keratins can affect the appearance of the filaments they form [14] . It is likely that ill vitlo the pathogenic keratin mutations compromise the resilience of the intracellular supportive cytoskeleton of the keratinocytes, rendering them less resistant to physical trauma.
In this study, we report mutations creating a serine-to-proline substitution and an asparagine-to-serine substitution in the helix IA subdomain of the keratin 1 polypeptide, seen in affected members of two fami lies carrying BCIE. Previously, all mutations found in the conserved 1A domain have been within type I keratins, and mutations in type II keratins have all been in other domains (head HI , helix 2B). These are the first examples of mutations in the helix 1 domain of a type II intermediate fil ament protein. We also report arginine-to-proline and arginine-to-serine mutations in helix 1A of keratin 10 rroducing the disease. These four diverse mutations in helix 1A 0 suprabasal epidermal keratins all produce severe BCIE phenotypes. Knowledge of where the mutation-sensitive points are in the proteins will help us to understand how keratin filam ents are assembled and how they function, and will clarify the nature of these mechano-bullous diseases and lead to development of better treatment.
MATERIALS AND METHODS
Transmission Electron Microscopy Perilesional skin biopsy specimens were fixed in half-strength Karnovsky fixative, post-fixed in osmium tetroxide, dehydrated in ethanol, and embedded in Epon, largely as described [8] were further stained with uranyl acetate and lead citrate and examined in a Jeol 100CX electron microscope operating at 60-80 kV .
lmmunoelectron Microscopy The specimens, derived from the same skin biopsy as the tissue used for transmissio n electron microscopy (above), were divided into subsamples no larger than 0.5 mm\ soaked for 1 h in 20% glycero l in phosphate-buffered saline (PBS) as a cryoprotectant, plunge-frozen in liquid propane at -190 ·C using a Leica KF80 apparatus, subjected to freeze substitution in methanol using Leica CS-Auto apparatus, and embedded in Lowicry l K11M resin [8) . Ultrathin sections were collected on nickel grids and incubated with rabbit polyclonal antiserum to keratin 1 (RbaK1 [15] ). After extensive buffer washes, further incubations were performed using appropriate I-nm go ld-conjugated seco ndary antibodies (Auroprobe One, Amersham International plc., Amersham, Bucks, UK). The gold particles were silver enhanced (IntenSE M, Amersham, UK) for easy recognition. Negative control studies included the use of normal rabbit serum instead of the specific primary antibody.
Polymerase Chain Reaction (PCR)
KeratilJ 1: A 578-bp genomic DNA fragment was amplified by primers 5' TIC CGG GTC TGG GTA CCG AAG 3' (desi gnated K1pl, sense strand) and 5' CAC CTT TGT CAA TGA AGG AGG CAA 3' (K1p7, antisense strand). Primer K1p1 is located at the start of the head domain coding sequence; Klp7 spans the exon1/intron1 junction in the lA domain.
Keratin 10: A 590-bp genomic DNA fragment was amplified by primers 5'
GAT ACA GCT CAA GCA AGC ACT ACT 3' (K10p14, sense strand, head domain) and 5' GTA GTA TIT GCT GTA GTC ACG AGG C3' (K10pll, antisense strand, linker L1 domain).
PCR Conditio tiS:
Approximately 500 ng of genomic DNA was used per 100j.Li reaction containing 1.5 mM MgCI 2 , 0.2 mM each dNTP, 10% dimethylsulfoxide, 0.5 Jig/ ml each primer, and 2.5 U Taq polymerase (Amplitaq). After an initial incubation at94 · C for 5 min, PCR was performed for 30 cycles consisting of94·C for 30 seconds, 60 · C for 1 min, 72·C for 2 min on a DNA Thermal Cycler (Perkin Elmer Cetus, CAl· Cycle Sequencing PCR fragments were resolved on 1.5% lowmelting-point agarose gels and purified using Gelase (Epicentre, USA). Purified templ ates (50 fmol approximately) were sequenced using the DS-Cycle sequencing system (BRL, Bethesda, MD) with [32P) end-labeled primer. The following PCR program was used for sequencing: 20 cycles consisting of94·C for 30 seconds, 55·C for 30 seconds, 72·C for 60 seconds, followed by 10 cycles of 94·C for 30 seconds, 72·C for 60 seconds. Samples were resolved on standard 6% denaturing sequencing gels. K 1 PCR fragments were sequenced initially with K1p7, and the reverse strand in the region of the mutation was also sequenced using K1p8 (5' TCT GCC C TC CTG GTG GCA TAC AAG 3') for confirmation. Similarly, K10 PCR fragments were sequenced using K10p11 in the first instance and the opposite strand sequenced with K10p7 (5 ' GGA GGA GAT GGT GGC CTT CTC TCT 3') for confirmation of murations.
Mutation Screening by Restriction Fragment Length Polymorphism (RFLP)
Family 1: PCR was performed with primers K1p7 and K1p8 as described above with the following modifications. The PCR volume was reduced to 50Jil. The PCR program consisted of an initial incubation at 94· C for 5 min, followed by 30 cycles consisting of 94·C for 30 seconds, 60·C for 30 seconds, 72 ·C for 45 seconds. Following PCR, 10 Jil of 5 X MaeIII buffer and 1 U MaelII restriction enzyme (BCL) was added per 40 Jil PCR reaction mixture. After overnight digestion ar 55 ·C, samples were analyzed on 4% Nusieve agarose TBE minigels. The 159-bp PCR product amrlified from normal alleles contains two MaelII sites producing fragments 0 27,40, and 92 bp. Digestion of the mutant allele yields fragments of 27 and 132 bp so that an additional 132 bp band was observed in affected heterozygotes.
Family 2: PCR was performed using primers K1p20 (5' AGG TGA AGT CTCGAGAAAGGG 3') and Klp21 (5' CGTTCG CAAAACATCCTT TT 3') using the reaction conditions above with the following program: 94·C for 30 seconds , 55·C for 1min, 72·C for 1 min, 30 cycles. Following PCR, 10 Jil 5 X DdeI buffer and 1 U DdeI was added per 40 Jil PCR reaction. After overnight incubation at 3rC, digests were analyzed as above. The 193-bp fragment produced does not normally conrain a DdeI site. However, the mutation in this family produces a DdeI site 36 bp from one end; digestion of the PCR product from the affected individual results in the appearance of additional bands of 157 and 36 bp due to the mutant allel e as well as the 193-bp band . Protein Structure Predictions The plots shown in Fig 6 show the results of analysis carried out on the co mplete amino acid sequence of helix 1A of human keratin 1 pins the a -helical portion of the H1 subdomain of the non-helical head region (residues 172-214 inclusive), using the Garnier algorithm of GeneWorks 2.1 (Intelligenetics Inc.). The analogous region of K10 was also analyzed. PredIctIOns were based on calculations carried out using eight residues on either side of th e target residue as recommended [16) .
V2 Domain Polymorphism in Keratins 1 and 10 The V2 subdomain of K 10 was amplified by PC R using the primers described elsewhere [17] with the following modifications. The thermal cycling program used was as described for Klp1 and K1p7 (above) and 10% dimethylsu lfoxide was added to the reaction mix. Formamide and glycerol were omitted from the reaction. The resulting reaction product was ana lyzed on 3% Nusieve TBE gels. The V2 subdomall1 of K1 was ampltfied as above with the following primers: Klp12 (sense strand) = 5' GTG AGC ACA AGC CACACCAGC 3' and K1p13 (antisense strand) = 5' TTG TTA GTG ATG CTG GGG GAG 3' . The PCR fragments were visualized by end labeling of one primer and separation on a 6% sequencing gel. This reaction produced a 475-bp product from all members of the family ana lyzed.
RESULTS
Electron Microscopy A skin biopsy from an affected individual (the proband in pedigree 1 [Fig 1] ) in a family carrying BCIE was examined by transmission electron microscopy (Fig 2) . B listering was found to occur within the suprabasa l cell layers of the epidermis . Figure 2 illustrates the fil ament abnorma li ties observed in this patient as pronounced aggregates in the granular (Fig 2a) and spinous (Fig 2b) layers of the epidermis. Basal cells appeared normal.
The diagnosis was therefore co nfirmed as BCIE, and distinguished from other ichthyoses or disorders causing hyperkeratosis. Figure 2a shows that much of the aggregated keratin forms a ring or sh ell around the nucleus, which is still separated from the nuclear envelope by a thin rim of cytoplasm. Other material of different electron density is associated with this, probably other components of differentiating keratinocytes. Filament clumps were shown to be selectively stained with specific antisera to K1 and K10 by immunoelectron microscopy (Fig 2b) , implying the involvement of at least one of these cwo copolymerizing keratins in the disease. Very similar results were obtained for individuals from families 2 -4 in this study. Figure 2b also demonstrates that desmosomes are still present and appear to be intact, and that some filamentous material is still attached to them .
peR Sequencing Keratin 1 Sequence Corrections: Genomic DNA was extracted from skin fibroblast cu ltures and/or blood samples from four affected and one unaffected member of family 1 (Fig la) . Similarly, genomic DNA was obtained from the affected member and the unaffected individuals in family 2.
A 578-bp fragment of genom ic DNA comprising the coding bees of family I were found to be heterozygous for a T I286 C transition in codon 185 of K1, which thus encoded a proline residue instead of the normal serine (Fig 3, EMBL accession number X69758) . The unaffected member did not have this mutation, nor was it present in six unrelated control sequences. The mutation was confirmed by sequencing of the reverse strand using an internal primer. The mutation occurs in the recognition site for the restriction enzyme MaeII! thus allowing rapid screening for this mutation in the general population (Fig 4) . No change in this site was observed in 60 unrelated normal individuals, i.e., 120 separate alleles, indicating that this change is unlikely to be a polymorphism in the general population. The affected individual in family 2 was found to be heterozygous for a A l293 G transition in codon 187 of K1, producing a asparagine to serine transition (Fig 3) . The mutation was absent from the six unaffected members of the family . The base change in this family creates a new Dde1 site allowing screening for this mutation in the normal population. No additional site was observed in 60 unrelated normal individuals (Fig 4) .
The positions of these mutations, together with two other mutations in K1 previously reported to be present in patients with BCrn [11 -13] , are shown in Fig 5 relative to the consensus domain structure of keratin polypeptides. Like the mutations in K5 and K14 that cause the analogous disease EBS, and those reported in KlO causing BeIE, the mutations appear to cluster in two highly conserved regions aro und i) the start (in HI, 1A) and Ii) the end (helix tennination peptide) of the a-helical rod domain, with the exception of one mutation in helix 2B ofK14 reported to cause a Koebner form of EBS [5) . This is consistent with transfection experim.ents [19 ,20J and il1 vitro filament assembly studies [21 ,14] with keratins carrying deletions and point mutations in the ends ohhe rod domain, which indicate that these regions are essential for normal polymerization. The mutations reported here occur close to the start of the rod domain, although the altered S185 residue is not so highly conserved as those previously observed to be mutated. In contrast, the mutated N 187 residue in family 2 is very highly conserved between all type I, II, and III intermediate filament proteins, thus one would expect mutations here to have some effect.
Keratin 10 Mutation s:
A 590-bp fragm.ent of the KI0 gene was amplified by PCR. This fragment includes most of the head domain, helix lA and linker Ll. This was directly sequenced with the reverse primer initially used for amplilication and the mutations were confirmed by sequencing of the sense strand with an internal primer.
The affected individual in family 3 was found to be heterozygous for a point mutation G 2I4o C that produces an arginine-to-proline substitution in codon 156 at the start of the helix 1 A domain of Kl 0 (Fig 3) . Similarly, the affected individual in family 4 was found to have a point mutation C 2139 A that changes arginine to serine in the same codon of KlO (Fig 3) . The unaffected parents in both these families had no alterations in this region by direct sequencing or PCR screening. Both mutations observed in families 3 and 4 disrupt a recognition site for the restriction enzyme Ad!. A PCR-based Ad! RFLP assay was used to screen unaffected members of both families and a population of 60 unrelated, unaffected individuals. An additional band was only seen in PCRs from the two affected individuals (Fig 4) . The positions of these and previously reported mutations [11] [12] [13] within the protein are shown in Fig 5. The affected residue RI56 is completely conserved within the type I and type III intermediate filament proteins and thus a point mutation at this position is likely to be detrimental to the assembly and/or structural integrity of keratin intermediate filaments.
Effects of Mutations on Predicted Protein Structure
Substitutions in Kerati" 1: At position 185 of human Kl there is a serine residue. Most human type II keratins have threonine at this position, although this residue is leucine in human K4 and alanine in human K7. Analyses of this domain according to the Garnier method [16] predict a tendency to form a-helix. In comparison, a proline substitution at residue 185 would cause a major disruption of the helix according to Garnier predictions (Fig 6) , consistent with the helix forming values of [22, 23] . Interestingly, the threonine alternative observed at this position in most type II keratins increases the predicted helicity slightly, and the natural sequences observed in K4 and K7 both give a considerably stronger prediction of a-helicity (plots not shown). Subtle variations such as this between keratins may reflect their individual tissue-specific functional requirements.
By contrast, the Kl N t87S mutation observed in family 2 is a relatively conservative transition because both serine and asparagine are uncharged under physiologic conditions. Asparagine, however, has a slightly larger side chain. Garnier prediction for this mutation in the 1A domain of K 1 indicates that the tendency to form part of an a -helix is unchanged. Interestingly, the phenotype of the pati ent carrying this m utation is severe and very similar to that observed to that of patients in family 1 carrying the S!8SP mutation. It appears therefore that it is not m.erely the a-helical conformation of this part of the lA dotnain that is necessary for the correct function ofKl/l0 intermediate filaments, but that residues in this region are involved in other important interacti ons. This is consistent with current thinking on the higher-order filament assembly of keratin dimers, where there is evidence for an overlap of about 10 amino acids between the ends of rod domains in the assembled fil aments [24] .
Substitutions in Keratin 10
The K10 mutations observed in families 3 and 4 produce similar Garnier predictions to that obtained for the K1 mutations above (Fig 6) . The R 156 P mutation is again predicted to be hi gh ly disruptive to the a-helical conformation of this domain, whereas the R! S6S mutation is much less damaging to THE JOURNAL OF INVESTIGATIVE DERMATOLOGY the predicted a-helix formation. In this case , a positively charged side chain is replaced by a polar, non-charged side chain so one might expect this to adversely affect the formation of dimers or higher-order structures.
The mutations seen here to cause BClE therefore demonstrate the importance of the a-helical lA rod domain in maintaining the structural and functi onal integrity of keratin intermediate filam"ents in differentiated epidermal cells. Substitution of a helix-breaking amino acid seriously disrupts the conformation of this functional domain and leads to a disease phenotype in two cases. In two other instances, although the mutation is apparently less damaging to a -helix conformation, aberrant keratin filaments are observed histologically and the disease phenotype is similar. This demonstrates that the precise amino acid sequence of this part of the 1 A domain of Kl and K10 is vital for production of functionall y correct filaments and underlines the probable role of these conserved regions in higher-order fil ament assembly [24] .
Phenotypic Variation and V2 Domain Polymorphism An aspect of BClE that has yet to be addressed is the findin g that the clinical phenotype can vary greatly within famili es, and also with the age of the patient. Both these forms of variatio n are found in family 1 reported here. The affected individual in generation II (Fig  7) was very severely affected in childhood, with t!l e majority of the skin hyperkeratotic. The severity has markedly decreased with age (patient is now in her mid 40s) and now only the hands, feet, and some flexor surfaces are affected. The patient does not use any medication. Patient III! has an similar phenotype, whereas patients lII2 and IlI J have very mild and localized changes. The occurrence of severe and mild phenotype in family 1 is indicated as S or M, respectively, in Fig 7. These findings are interesting because each of these patients are shown h ere to carry the identical mutation in K 1. We have made similar observations within other BC IE kindreds (not shown here). It is possible that an otherwise benign polymorphism, either in keratins or in th eir associated accessory proteins, may have a modifying affect on the expression of the phenotype. The effect is unlikely to be due to mosaicism, as the lesions are not obviously focal even in the proband, who is already at least the second generation to be affec ted. Insertional polymorphism is known to occur in the variable non-helical head and tail domains ofK1 and KI0 [16 ,25] ' Recent studies imply that although these end domains may not be essential for fil ament assembl y, th ey are probably involved in maintaining the stability of 10 nm intermediate fil ament network [26, 27] . Because the V1 and V2 domains are the regions that vary most between keratins, these domains are thought to influence the qualities of the fil aments required in specific tissues, such as strength or flexibility. Insertional polymorphism of this type might therefore be involved in phenotypic variation within BCIE. T o test this, the V2 do mains of Kl and K10 were amplified by peR from genomic DNA taken from all members of the family . No size variatioll was observed in the V2 domain of Kl in the family, with all members being homozygous.
Insertional polymorphism, however, was observed in the KI0 V2 domain, where two alleles differing by approximately 75 bp were seen, represe nting an insertion of about 25 am.ino acids. However, variation in the severity of the phenotype clearly does not segregate with this polymorphism, as shown in Fig 7 . 
DISCUSSION
The patients in the families under study expressed the hallmarks of BCIE, the occurrence of blistering and keratin tonofilament aggregation within the suprabasal layers of epidermis. Immunoelectron microscopy showed that Kl and KIO were prominent components of the filament clumps. DNA sequencing revealed underlying genetic defects in the IA domain of keratins 1 and 10. In Kl these were S!8SP and N!87S; in K10 mutations R! S6P and R!S6S were found.
These mutations are not prese nt in the normal population. DNA encoding the ends of the rod domains ofKl and KI0 have now been seguenced from 10 families with BCIE in this laboratory; only these four families show mutations in these regions. It is supposed that the ge netic defects in the other six kindreds lie elsew here in these keratins, or in other epidermal differentiation keratins such as K2e, or in a non-keratin gene(s).
The importance of the helix lA domain in assembl y and/or integrity of the Kl / KIO fil ament networks in suprabasal keratinocytes is demo nstrated by these mutations, which are analogous to the K5/ K14 dependence on the same domain for filam ent integrity in the basal cells in EBS. The early appearance of reciprocal clustering of mutations at the start of the type I rod domain and at the end of the type II rod domain was probably due to small sample numbers; it is now known that mutations at either end of the central rod domain of either a type I or type II keratin can cause blistering disorders. It seems probable that EBS-causing mutations will also be found at the start of helix lA of K5 . To date there have been no mutations found in the helix termination peptide of a type I keratin . Wh eth er this is because such mutations are non-pathologic, or are lethal, or whether this apparent bias is still due to small sample size remains to be seen.
Although the mutation Kl SI8SP observed here is not in as hig hly a conserved residue as those reported previously, the transition from serine to proline in this a-helical domain is predicted to be highly disruptive. It appears that the IA domain must exist in an a-helical conformation or th e cytoskeletal properties of the filament network are significantly compromised. Whether the defects interfere with nucleation, elon ga tion, or higher-order filament assembly is U11-clear. (right) helix lA domains an d th e four mutant keratins described here. Proline is see n to cause severe disruption of the a-helix in either protein; however, the Kl N IB7S and the KI0 R, s6S mutations have comparatively mild effects on the predicted helicity c r this region.
In contrast, the N 187S occurs in a res idue that is conserved between all type I, II, and III intermedi ate filam ent proteins characterized thus far. The transition from asparagine to serine is semi-conservative, both amino acids having uncharged polar side chains. However, this mutation nevertheless produces a clinical phenotype that is as severe as those observed with proline substitutions demonstrating that even slight changes in this highl y conserved region of the lA domain calmot be tolerated for functional fil ament formation.
The KlO mutations reported here both affect the conserved residue R I56 in the lA domain. The mutation R IS6 H in KIO has been previously reported to be linked to BCIE/EHK, and the analogous arginine (R125) ofK14 has also been found to be mutated to histidine or cysteine in patients with the Dowling-Meara form of EBS. Of all the keratin mutations identified to date in mechano-bullous diseases of which we have information, at leas t 14 of 32 affect exactly this arginine residue, so it is not surprising to find two more in the four mutations we document here. The DNA motif CpG, in w hich the C is often methylated in mammalian coding sequences, occurs in However, this extended tail domain is seen to be unrel ated to the observed ph enotypes. this arginine codon in both KIO and K14. Methyl-C can be spontaneously deaminated to become T, resulting in C-T (or G-A mutations). The arginine-to-histidine and arginine-to-cysteine mutations reported represe nt the two possible products of deamination of the methyl-C on the antisense and sense strands, respectively. The two mutations described here in this codon involve C-A and G-C transitions and therefore CpG deamination events are not the only cause ofBCIE mutations in this codon, although these are probably more common. This residue is very highly conserved in the type I keratins and the range of mutations seen so far in this codon in the I A domain show that a variety of amino acid substitutions are deleterious to the ;11 vivo function of the Kl/I0 cytoskeleton.
Taken together, the mutations reported here in KI and KIO emphasise the importance of the lA domain in the function of keratin intermediate filaments. It is interesting to note that all the helix lA mutations found thus far that are associated with filament aggregation and severe clinical phenotype are clustered near the start of the rod domain. The only mutation seen at the internal end of this domain (E144A in K14) produces a very mild recessive EBS phenotype despite being a non-conservative amino acid substitution l28]. Heterozygous individuals in that particular family showed no clinical features of the disease. There is a marked difference in the degree of conservation observed between the amino-terminal start of lA (which is highly conserved between the various keratins) and the carboxyl-terminal end of the domain (which is only moderately conserved). Although the sample number is still small, there would appear to be a broad correlation between disease severity and the position of the mutation within helix lA. This in turn correlates well with data suggesting that the first 10 or so residues of lA are involved in overlap interactions between dimers in the assembly of keratin filament structures [24] . From this, one would predict that mutation in these residues (or close by) would have much more serious effects on filament formation than mutations near the carboxy-terminal terminal end of helix lA. This is supported by all the mutations reported to pate.
The possible role of known polymorph isms in V2 domains ofKl and KI0 in the marked phenotypic variation exhibited in this family was investigated, but results failed to indicate any relationship between size of these domains and phenotypic heterogeneity. Genetic linkage analysis of a large kindred with highly polymorphic DNA markers may reveal the involvement of non-keratin genes encoding accessory proteins in this phenomenon. Data have been reported that suggest linkage of the rare Ogna form of EBS to loci on cllfomosome 8 [29] . Because all keratin genes cloned to date have been found to map to gene clusters on chromosomes 12q and 17q, it seems possible that a non-keratin gene may be involved in this disorder. Genes for keratin-associated or regulatory proteins may playa hitherto unrecognized role in keratin filament assembly, structural integrity of the cytoskeleton or in phenotypic variation of these diseases. Identification and characterization of more accessory proteins may be essential to gain complete understanding of keratin filament biology. 
